Startup-085

Startup-085

Copenhagen, Denmark
Roxiant is a preclinical stage biotech company developing a new class of medicines to slow, halt, and reverse neurodegenerative diseases. Our drug candidates uniquely activate multifactorial repair mechanisms that counteract age-related cellular damage in human cells.